{
  "run_id": "run_2026-02-23T17-47-37-753Z_8x89ku",
  "kind": "ideas",
  "updated_at": "2026-02-23T17:47:58.885Z",
  "items": [
    {
      "name": "AI carbon accounting for mid-market (Scope 3)",
      "why_now": "Only 7% report all scopes; 69.5% S&P 500 have Scope 3; CarbonAnalytics shows 80% manual reduction. SEC uncertainty creates demand for voluntary best-practice reporting.",
      "description": "SaaS that automates Scope 3 data collection and carbon accounting for mid-market ($50Mâ€“$500M revenue). Integrate with Climate TRACE, supply chain data. Target: manufacturing, retail, logistics.",
      "signals": [
        "7% all-scopes",
        "80% manual reduction",
        "Scope 3 gap"
      ]
    },
    {
      "name": "FDA AI compliance platform for digital health",
      "why_now": "FDA Jan 2025 draft guidance; comment April 7. 1000+ AI devices authorized; lifecycle + postmarket monitoring required. No vertical SaaS for FDA AI compliance.",
      "description": "B2B platform for health tech: design controls, bias documentation, postmarket monitoring for AI-enabled devices. Target: digital health startups pre-510(k).",
      "signals": [
        "FDA Jan 2025",
        "1000+ devices",
        "Lifecycle guidance"
      ]
    },
    {
      "name": "Voluntary carbon credit integrity layer",
      "why_now": "VCM $535M 2024 (down from $2.1B); GAO limited federal role; Oxford framework for regulation. Credibility gap creates demand for verification/ratings.",
      "description": "API or platform that rates/verifies voluntary carbon projects against Oxford-style criteria. Sell to corporates, insurers, registries.",
      "signals": [
        "$535M VCM",
        "GAO limited role",
        "Integrity concerns"
      ]
    }
  ]
}